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Summary
Many patients undergoing elective or emergency surgery have a cardiac 
implantable electronic device (CIED), and their number continues to grow. 
This joint position paper of the Swiss Working Group on Cardiac Pacing 
and Electrophysiology of the Swiss Society of Cardiology and the Cardio-
vascular and Thoracic Anaesthesia Group of the Swiss Society of Anaes-
thesiology and Resuscitation gives a concise overview of the pre-, intra- 
and postoperative issues and management of pacemaker and de fibrillator 
carriers in the setting of electrocautery used for surgery and strives to give 
practical and readily applicable guidance stressing the simple use of a 
magnet placed over the CIED.
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Abbreviations
ATP: antitachycardia pacing
CIED: cardiac implantable electronic device
CRT: cardiac resynchronisation therapy
EMI: electromagnetic interference
ICD: implantable cardioverter defibrillator
Introduction
In Switzerland approximately 45 000 patients live with 
a cardiac implantable electronic device (CIED). CIEDs 
comprise cardiac pacemakers, implantable cardio-
verter defibrillators (ICDs) and devices for cardiac re-
synchronisation therapy (CRT). Their number contin-
ues to grow and these patients are already undergoing 
elective or emergency surgery in great numbers. The 
Swiss Working Group on Cardiac Pacing and Electro-
physiology published a checklist for the perioperative 
management of CIED patients in 2009 (www.pace-
maker.ch/download/Checklist_Literature.pdf). 
The current recommendations update the previous 
ones and represent a joint position paper of the Swiss 
Working Group on Cardiac Pacing and Electrophysiol-
ogy of the Swiss Society of Cardiology (SSC) and the 
Cardiovascular and Thoracic Anaesthesia Group of the 
Swiss Society of Anaesthesiology and Resuscitation 
(SGAR). It has been approved by the boards of the SSC 
and the SGAR.
In clinical practice, many patients undergo surgery at 
hospitals where reprogramming of the device is not 
possible. The main objective of these recommenda-
tions is to allow surgery at local centres as often as pos-
sible and to avoid unnecessary delays or referrals to 
centres with a cardiology service. There is also the real 
risk that the patient’s device is left programmed in an 
asynchronous pacing mode or that life-saving ICD 
therapy remains inactivated. In fact, the vast majority 
of patients can be operated on with the simple use of a 
magnet [1]. Following the modified recommendations 
of the Canadian Heart Rhythm and Anesthesiologists’ 
Society this position paper gives a pragmatic approach 
to elective and emergency surgery on CIED patients, 
stresses the importance of understanding the simple 
use of a magnet and explains in which conditions re-
programming really is necessary [1].
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Potential perioperative risks
The main concerns when using cautery in a patient 
with a CIED is that it may inhibit pacing in a pace-
maker-dependent patient or cause inappropriate anti-
tachycardia pacing (ATP) or shock therapy in an ICD pa-
tient (table 1). Furthermore, though less threatening, 
inappropriate rapid pacing may occur if the rate re-
sponse remains activated. The likelihood of occur-
rence of these events and the severity of their conse-
quences depends on four factors:
1. Site of surgery
 Sensing electromagnetic interference (EMI) is more 
likely if surgery is performed <15 cm away from the 
device, i.e., above the umbilicus.
2. Underlying cardiac rhythm
 Only a minority of pacemaker patients are comple-
tely pacemaker-dependent and at risk for prolonged 
asystole. For the remainder, short periods of EMI 
(<5 seconds) during cautery will not result in asys-
tole even if they temporarily inhibit pacing. 
3. Type and programming of the device
 EMI is more likely in patients with unipolar leads 
(which have become very rare) and those with a 
very high programmed sensitivity. 
 Inappropriately rapid pacing can be caused by ma-
nipulation in the vicinity of the generator (“activity 
sensors”) or by mechanical ventilation or monito-
ring of respiratory rate in patients with rate-modu-
lation technology (minute ventilation sensors) [2]. 
These minute ventilation sensors are used in Bos-
ton Scientific and Sorin devices, and measure trans-
thoracic impedance. Mechanical ventilation or the 
current delivered by external respiratory rate mo-
nitors may lead to rapid ventricular pacing which 
must not be misinterpreted as ventricular tachy-
cardia. Hence suspension of rate response during 
the procedure should be considered; this can be ac-
complished with a magnet in pacemaker patients, 
but requires reprogramming with ICDs.
4. Type of cautery utilised 
 EMI is more likely to occur with unipolar cautery. 
The grounding pad of the coagulation system 
should therefore be positioned away from the de-
vice (e.g., upper thigh). Bipolar cautery should be 
preferred over uni polar cautery, with bursts lasting 
<5 seconds with 5-second pauses between bursts. 
When using an argon beam coagulation system, re-
programming of the pacemaker in a dependent 
 patient should be considered, since experience is 
still limited [1].
Of course, other consequences during surgery can im-
pair the functionality of the device (e.g., physical dam-
age to the leads, increase of pacing thresholds with loss 
of capture, increase of ICD defibrillation threshold ow-
ing to a perioperative pneumothorax, etc.).
Principle of magnet use
CIEDs possess a reed switch which is activated when a 
magnetic field is applied. In short, the reed switch con-
sists of two magnetic metal strips, that are usually sep-
arated, in a glass capsule. The magnetic field will bring 
these two strips together, which results in a sudden 
voltage change sensed by the sensing amplifier that 
will trigger programmed functions such as asynchro-
nous pacing [3]. Newer devices that are designed to be 
magnetic resonance imaging-safe are equipped with 
Hall-effect sensor switches, which trigger an electronic 
switch when activated by a magnetic field. 
Table 1: Patient- and procedure-related risk factors. 
Pacemaker Implantable cardioverter difibrillator
Device always 
accessible 
and outside 
operation field
Bradycardia 
function
Tachyarrhythmia 
function
No or minimal 
cautery
No reprogramming
Have magnet 
available
No reprogramming Apply magnet
Significant 
cautery
Not pacemaker-
dependent
Yes No reprogramming
Have magnet 
available
No reprogramming Apply magnet
No No reprogramming No reprogramming Reprogramme
Pacemaker- 
dependent
Yes Apply magnet Consider reprogram-
ming
Apply magnet
No Reprogram Reprogram Reprogram
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Pacemakers (table 2)
Applying magnets to pacemakers serves both diagnos-
tic and therapeutic purposes. The magnets should have 
a field strength >10 Gauss aligned with the reed switch 
in order to activate the switch (magnets provided by 
the industry have field strengths >90 Gauss). In very 
obese persons two magnets may be required to acti-
vate the reed switch. 
The application of a magnet switches the programmed 
mode to an asynchronous mode and inactivates the 
rate response feature. Biotronik pacemakers are an ex-
ception in that in the default “auto” setting they will 
pace asynchronously for 10 beats only and then revert 
to the programmed synchronised mode.
Implantable cardioverter defibrillators (table 3)
Generally, magnet application suspends antitachy-
cardia therapy without any effect on the pacing mode. 
Sorin ICDs are an exception and will pace with the 
magnet rate. This means that the pacemaker part con-
tinues to function in the programmed synchronous 
mode, including rate responsiveness. Approximately 
25% of ICD patients also require some kind of anti-
bradycardia pacing.
Boston Scientific ICD can respond in a complex fash-
ion. Older devices (PRIZM and VITALITY 1 families) 
have the “change the mode with magnet” feature that 
can be programmed on. In that case magnet placement 
can permanently switch antitachycardia detection and 
therapy off. In order to reactivate it, the magnet has to 
be reapplied for >30 seconds. In the more recent Bos-
ton Scientific models, the “change the mode with mag-
net” feature is absent and these ICDs behave like the 
others. If in doubt, interrogating the Boston Scientific 
defibrillators postoperatively is strongly recom-
mended. 
Minimal preoperative care
Before surgery one must ascertain whether the patient 
carries a CIED and if so which type. Usually, the patient 
presents with a pacemaker/ICD identification card that 
contains all important information. In the case of an 
emergency or other circumstances preventing the pa-
tient from providing this information, a scar in the left 
or right pectoral region should be sought. In most 
instances, the device can be palpated. The minimal in-
formation that has to be obtained before surgery is 
whether the patient carries a pacemaker or an ICD. This 
is important since the response to magnet application 
differs and may become an issue in a pacemaker- 
dependent patient. This information can easily be 
Table 3: Manufacturer-specific implantable cardioverter defibrillator responses to magnet application.
Manufacturer Response to Brady function Response to Tachy function Remarks
Biotronik None Detection/therapy: OFF Since Lumax: during maximum 
of 8 hours
Boston Scientific None *
Medtronic None Detection: OFF Patient alert “ON”: continuous tone: 
OK, alternating tone: alarm
St.Jude Medical None Detection/therapy: OFF Can be programmed to 
“Ignore magnet”
Atlas and Epic: vibratory alert
Sorin/Ela Pace in programmed mode 
at magnet rate (96 bpm)
Detection/therapy: OFF
* If the function “Enable magnet use” is “ON” (nominal): 30” beep synchronous to R wave, then: i) continuous beep (some old models): Tachy mode 
OFF, magnet can be removed; to activate therapy magnet must be reapplied, ii) intermittent beep (new models): magnet must be left to inhibit anti-
tachycardia therapy. If the function “Enable magnet use” is “OFF”: no effect.
Table 2: Specific responses of different pacemakers on magnet application.
Manufacturer Response* Remarks
Biotronik Auto: DOO/VOO/VDO, 90 bpm for 10 beats, 
then back to synchronous
Can be programmed to Async 
or Sync response
Boston Scientific DOO/VOO/VDO, 100 bpm Can be programmed OFF
Medtronic DOO/VOO/VDO, 85 bpm
St.Jude Medical DOO/VOO/VDO, 100 bpm Can be programmed OFF
Sorin/Ela DOO/VOO/VDO, 96 bpm
* Depicted are the default settings of the device. Initial response is pacing in an asynchronous mode (DOO/VOO/VDO). 
Rates refer to devices at beginning of life (BOL).
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 obtained from a simple chest X-ray (figs 1 and 2). An ICD 
can easily be recognised from the shock coils that are 
identified as a “thickening” of the lead in the right ven-
tricle. Many (“dual-coil”) ICD leads carry a second coil 
in the superior vena cava. If these are discerned, the pa-
tient should be treated like an ICD carrier. The presence 
of a third pacemaker lead pointing posteriorly indi-
cates that this patient is a CRT-carrier in whom periop-
erative fluid challenges should be avoided since he or 
she had or has heart failure. Often, however, additional 
leads are simply abandoned leads (without contact to 
the generator on the chest X-ray).
It is important to know if the patient is pacemaker- 
dependent or not. A conservative assumption of pace-
maker dependency is an intrinsic ventricular rate 
<40 bpm (measured by temporarily modifying the 
baseline rate to 40 bpm with a programmer) or if only 
paced QRS complexes are visible on the ECG. In CRT-pa-
tients this cannot be applied since 100% biventricular 
pacing is desired.
If possible, one should try to identify the manufacturer 
and model of the CIED. This is pertinent in pacemak-
er-dependent patients since the pacemakers of one 
manufacturer (Biotronik) revert after positioning of 
the magnet from an asynchronous to the programmed 
mode after ten asynchronous beats and may require 
reprogramming.
In ICD patients, the magnet will deactivate only the 
anti tachycardia therapies of the device and leaves the 
antibradycardia mode unaffected. Sorin ICDs set the 
pacing rate to 96 bpm without any change in pacing 
mode. One manufacturer (Boston Scientific) has a fea-
ture in some of their older models (Boston Scientific 
PRIZM and VITALITY 1) that permanently deactivates 
the defibrillator after 30 seconds. 
Intraoperative care
In all patients with an implanted CIED, the anaesthetic 
workplace must be equipped with a defibrillator with 
pacing capability. In cases where the patient is com-
pletely pacer dependent, or where the ICD functional-
ity will be switched off and where there is no unre-
stricted access to the patient’s torso, defibrillation/
pacing pad must be installed and connected to the ex-
ternal de fibrillator device preoperatively. 
Pacemakers
The CIED should be accessible for magnet application. 
If this is not possible, transcutaneous pads for external 
pacing, defibrillation and cardioversion should be 
posi tioned (at least 5 cm from the generator) or a mag-
net applied and fixed to the CIED prior to scrubbing-up 
the patient. 
If the patient is not pacemaker dependent and a rate- 
responsive mode (“R” function) is not programmed in 
a device using a minute-ventilation sensor (Boston 
Scien tific and Sorin devices), the operation may be per-
formed without magnet application or reprogram-
ming. If a device equipped with a minute- ven tilation 
sensor is left programmed in a rate-responsive mode 
for the intervention, the healthcare personnel must be 
aware of the risk of rapid pacing, which may be diag-
nosed and interrupted by magnet application to pace-
makers.
In suspected or known pacemaker dependency, a mag-
net should be positioned over the generator, which re-
sults in asynchronous pacing in a VOO, VDO or DOO 
mode at a manufacturer-specific rate (table 1). Alterna-
tively, the magnet may be applied only if inhibition by 
cautery is really observed (provided the device is read-
Figure 1: Chest X ray (postero-anterior) of a CRT pacemaker:
note the pacemaker leads in the right atrium (A), the right 
ventricle (V) and the quadripolar lead in the coronary sinus 
(CS) over the left ventricle.
Figure 2: Chest X ray (postero-anterior) of a single-chamber 
ICD: note the presence of a high-voltage defibrillation coil 
(HV) in the right ventricle.
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Figure 3: Perioperative management of patients with a pacemaker.
Figure 4: Perioperative management of patients with an implantable cardioverter-defibrillator.
PACEMAKERS (PM)
PM-DEPENDENT or 
RATE-RESPONSE mode No
• Perform intervention 
• Magnet or transthoracic stimulation as back-up 
Yes
ASYNCHRONOUS PACING @ magnet rate
Consider the following:
1. PM programmed to ignore the effect of the magnet :
BIOTRONIKmodels. (BOSTON SCIENTIFIC and ST. JUDE MEDICAL
models may  rarely be programmed to ignore MAGNET effect) 
2. Obese individuals or deeper implants: may need a second MAGNET to
achieve sufficient magnetic field (≥10 Gauss).
3. Site of MAGNET placement : usually best placed on top of the device.
4. Depleted PM battery
Asynchronous pacing
not established ?
PM reverts to initial rate and mode after MAGNET 
removal
Perform surgery
Yes No
Yes
No
Place MAGNET over PM generator
Remove MAGNET
Device interrogation with
proprietary programmer
• PM accessible AND no interference observed 
• Surgery >15 cm from PM / below umbilicus
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ily accessible), particularly in operations below the 
umbilicus or a distance of >15 cm to the device [4]. In 
the default setting, which will be encountered in the 
overwhelming majority of CIED carriers, Biotronik 
pacemakers will revert to a synchronous mode after 
10 beats. Should the need arise, the magnet may be re-
moved and reapplied, which will render the device 
asynchronous for the following 10 beats.
In very rare cases, asynchronous pacing can induce 
ventricular fibrillation by pacing in the vulnerable pe-
riod of the T-wave. Therefore, patients need to be mon-
itored and an external defibrillator must be present. In 
clinical practice, this rarely causes problems when 
some principles regarding cautery are kept in mind 
(see above).
Implantable cardioverter defibrillators
Regarding ICD carriers a magnet should always be 
 securely applied in order to disable the antitachycardia 
functions. In fact, we recommend magnet positioning 
over reprogramming since the device will always im-
mediately function as programmed after magnet re-
moval. There is an abundance of clinical anecdotes of 
fatal and near-fatal events linked to failure to restore 
appropriate device settings [5]. 
In a pacemaker-dependent ICD patient, however, the 
device has to be reprogrammed to an asynchronous 
pacing mode and the tachycardia therapies have to be 
disabled, because the pacing mode is not affected 
by magnet application. Other scenarios where repro-
gramming is recommended are if the patient has to be 
placed in an abdominal position (since the magnet 
may dislocate without notice), a secure magnet posi-
tion during surgery cannot be guaranteed for other 
reasons, or where a rate-responsive pacing mode is 
programmed with a minute-ventilation sensor (Bos-
ton Scientific devices).
Some ICDs will transiently emit an audible tone 
(e.g., Boston Scientific, Medtronic devices) or vibrate 
(St. Jude Medical) when coming into contact with the 
magnet, which is normal device behaviour. In cases of 
device reprogramming, institutions should have a 
standard operating procedure to ensure that the de-
vice functions will be correctly restored in a timely 
manner postoperatively.
Postoperative care
After the removal of the magnet, the programmed set-
tings are usually restored. If the device programming 
has been changed, it is critical to continuously monitor 
the patient and his/her ECG in an adequately equipped 
environment with the possibility of immediate ad-
vanced life support until the device is reprogrammed. 
After thoracotomy, the lead position should be ana-
lysed on a postoperative X ray and the leads checked if 
applicable. It is important to recognise, that pace-
maker-dependent patients have different physiologi-
cal responses to shock and that minute-ventilation 
sensors may have to be switched off in patients venti-
lated for a prolonged period postoperatively [6] or if 
the respiratory rate is being monitored externally.
Conclusion
The vast majority of patients with a CIED who undergo 
surgery will not experience any untoward effects and 
can be handled with the simple use of a magnet. The 
real challenge is to identify those few patients who are 
at higher risk and whose device should be repro-
grammed before and after surgery. These comprise 
pacemaker-dependent patients with a CIED that is not 
accessible during surgery and ICD patients whose pace-
maker function works in a rate-responsive mode using 
minute-ventilation sensors. The use of a magnet 
should be the preferred management since problems 
arising from forgotten, incomplete or faulty repro-
gramming cannot arise.
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